Vanguard Capital Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Vanguard Capital Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$239K	Buy	1,895 +3	+0.2%	+$395	0.16%	108
2026 Q1	$264K	Buy	1,892 +3	+0.2%	+$420	0.24%	84
2025 Q4	$232K	Buy	1,889 +3	+0.2%	+$365	0.19%	107
2025 Q3	$209K	Buy	1,886 +3	+0.2%	+$341	0.17%	119
2025 Q2	$209K	Buy	1,883 +4	+0.2%	+$426	0.21%	100
2025 Q1	$211K	Buy	+1,879	New	+$194K	0.26%	93
2021 Q3	–	Sell	-3,313	Closed	-$228K	–	163
2021 Q2	$228K	Sell	3,313 -5,563	-63%	-$371K	0.17%	129
2021 Q1	$582K	Buy	+8,876	New	+$572K	0.5%	50
2020 Q2	$297K	Buy	+3,862	New	+$296K	0.35%	77
2019 Q4	$360K	Sell	5,542 -379	-6%	-$24.7K	0.38%	80
2019 Q3	$375K	Buy	+5,921	New	+$387K	0.44%	74

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Vanguard Capital Wealth Advisors's GILD Position: Q2 2026 in Review

Vanguard Capital Wealth Advisors increased its Gilead Sciences (GILD) stake by 0.16% in Q2 2026, buying an estimated $395 and bringing the position to 1,895 shares worth $239K. The position accounts for 0.16% of the portfolio, ranked #108.

Vanguard Capital Wealth Advisors first reported a position in GILD in Q3 2019 and has held it in 11 quarters since. The position peaked at $582K in Q1 2021. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Vanguard Capital Wealth Advisors held 1,895 shares of Gilead Sciences worth $239K as of Q2 2026.
Vanguard Capital Wealth Advisors bought 3 Gilead Sciences shares in Q2 2026, an estimated $395.
Gilead Sciences made up 0.16% of Vanguard Capital Wealth Advisors's portfolio in Q2 2026, its #108 holding.
Vanguard Capital Wealth Advisors first reported a position in Gilead Sciences in Q3 2019 and has held it in 11 quarters since.
Vanguard Capital Wealth Advisors's Gilead Sciences position peaked at $582K in Q1 2021.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Vanguard Capital Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.